The role of various biomarkers in the evaluation of styrene genotoxicity

Cancer Detection and Prevention

Volumn 27, Issue 4, 2003, Pages 275-284

  Vodicka, P ^a   Koskinen, M ^e   Stetina, R ^b   Soucek, P ^c   Vodickova, L ^c   Matousu, Z ^a   Kuricova, M ^d   Hemminki, K ^f  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^d INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

^e ORION CORPORATION   (Finland)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

DNA damage; DNA repair capacity; Genotoxicity; Individual susceptibility; Styrene exposure

Indexed keywords

EID: 0041570131     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(03)00096-5     Document Type: Article

References (42)

1. World Health Organization. Air Quality Guidelines for Europe. Copenhagen: WHO; 1987. WHO Regional Publications, European Series No. 21.
2. Anonymous. Styrene. IARC Monogr Eval Carcinog Risks Hum 1994;60:223-320.
3. Nakajima T, Elovaara E, Gonzales FJ, et al. Characterization of the human cytochrome P450 isozymes responsible for styrene metabolism. IARC Sci Publ 1993;45:101-8.
4. Csanady GA, Mendrala AL, Nolan RJ, Filser JG. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man. Arch Toxicol 1994;68:143-57.
5. Anonymous. Styrene 7,8-oxide. IARC Monogr Eval Carcinog Risks Hum 1994;60:321-46.
6. Perera FP, Weinstein IB. Molecular epidemiology: recent advances and future directions. Carcinogenesis 2000;21:517-24.
7. Hemminki K, Koskinen M, Rajaniemi H, Zhao C. DNA adducts, mutations and cancer. Regul Toxicol Pharmacol 2000;32:264-75.
8. Collins AR. Molecular epidemiology in cancer research. Mol Aspects Med 1998;19:359-432.
9. 32P-postlabelling detection of DNA adducts in mononuclear cells of workers occupationally exposed to styrene. Carcinogenesis 1994;15:1309-15.
10. 32P-postlabelling of DNA adducts of styrene-exposed lamination workers. Carcinogenesis 1993;14:2059-61.
11. 32P-postlabelling. Carcinogenesis 1994;15:1949-53.
12. Vodicka P, Tvrdik T, Osterman-Golkar S, et al. An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers. Mutat Res 1999;445:205-24.
13. Koskinen M, Vodicka P, Hemminki K. Identification of 1-adenine DNA adducts in workers occupationally exposed to styrene. JOEM 2001;43:694-700.
14. Koskinen M, Plna K. Specific DNA adducts induced by some mono-substituted epoxides in vitro and in vivo. Chem Biol Interact 2000;129:209-29.
15. Bastlova T, Podlutsky A. Molecular analysis of styrene oxide-induced HPRT mutation in human T-lymphocytes. Mutagenesis 1996;11:581-91.
16. Zhao C, Vodicka P, Sram RJ, Hemminki K. Human DNA adducts of 1,3-butadiene, an important environmental carcinogen. Carcinogenesis 2000;21:107-11.
17. Czene K, Osterman-Golkar S, Yun X, et al. Analysis of DNA and hemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide: a pilot study. Cancer Epid Biomarkers Prev 2002;11:315-8.
18. Brenner DD, Jeffrey AM, Latriano L, et al. Biomarkers in styrene-exposed boatbuilders. Mutat Res 1991;261:225-36.
19. Walles SAS, Edling CH, Anundi H, Johanson G. Exposure dependent increase in DNA single strand breaks in leucocytes from workers exposed to low concentrations of styrene. Br J Ind Med 1993;50:570-4.
20. Somorovska M, Jahnova E, Tulinska J, et al. Biomonitoring of occupational exposure to styrene in a plastics lamination plant. Mutat Res 1999;428:255-69.
21. Tates AD, Grummt T, Van Damm FJ, et al. Measurement of frequencies of HPRT mutants, chromosomal aberrations, micronuclei, sister-chromatid exchanges and cells with high frequencies of SCEs in styrene/dichloromethane-exposed workers. Mutat Res 1994;313:249-62.
22. Bonassi S, Montanaro F, Ceppi M, Abbondandolo A. Is human exposure to styrene a cause of cytogenetic damage? A re-analysis of the available evidence. Biomarkers 1996;1:217-25.
23. Vodicka P, Soucek P, Tates AD, et al. Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res 2001;482:89-103.
24. Marczynski B, Peel M, Baur X. New aspects in genotoxic risk assessment of styrene exposure: a working hypothesis. Med Hypotheses 2000;54:619-23.
25. 6-guanine, DNA adducts DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis 1995;16:1473-81.
26. Sarmanova J, Tynkova L, Susova S, et al. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics 2000;10:781-8.
27. Hassett C, Aicher L, Sidhu S, et al. Human microsomal epoxide hydrolase genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994;3:421-8.
28. Nedelcheva-Kristensen V, Andersen T, Erikstein B, et al. Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTP1 and GSTT1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients. Pharmacogenetics 1998;8:441-7.
29. Singh NP, McCoy LT, Tice RR, et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
30. Collins AR, Dusinska M, Gedik C, Stetina R. Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 1996;104(3):465-9.
31. Alapetite C, Thirion P, De La Rochefordiere A, et al. Analysis by alkaline comet assay of cancer patients with reverse reaction to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer 1999;83:83-90.
32. Collins AR, Dusinska M, Horvathova E, et al. Inter-individual differences in repair of DNA base oxidation, measured in vitro with the comet assay. Mutagenesis 2001;16:297-301.
33. Vodicka P, Koskinen M, Arand M, et al. Spectrum of styrene-induced DNA adducts: the relationship to other biomarkers and prospects in human biomonitoring. Mutat Res 2002;511:239-54.
34. Zhao C, Vodicka P, Sram RJ, Hemminki K. DNA adducts of 1,3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks and cytogenetic end points. Environ Mol Mutagen 2001;37:226-30.
35. Vodicka P, Koskinen M, Vodickova L, et al. DNA adducts strand breaks and micronuclei in mice exposed to styrene by inhalation. Chem Biol Interact 2001;137:213-27.
36. Rydberg D, Skaug V, Hewer A, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18:1285-9.
37. Grzybowska E, Butkiewicz D, Motykiewicz G, et al. The effects of genetic polymorphisms of CYP1A1, CYP2D6, GSTM1 and GSTP1 on aromatic DNA adduct levels in the population of healthy women. Mutat Res 2000;469:271-7.
38. Whyatt RM, Perera FP, Jedrychowski W, et al. Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms. Cancer Epid Biomarkers Prev 2000;9:207-12.
39. Butkiewicz D, Grzybowska E, Phillips DH, et al. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ Mol Mutagen 2000;35:99-105.
40. Schoket B, Papp G, Levay K, et al. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. Mutat Res 2001;482:57-69.
41. Viezzer C, Norppa H, Clonfero E, et al. Influence of GSTM1, GSTT1, GSTP1 and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers. Mutat Res 1999;431:259-69.
42. Halberg LM, Bechtold WE, Grady J, et al. Abnormal DNA repair in lymphocytes of workers exposed to 1,3-butadiene. Mutat Res 1997;383:213-21.